| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910460441003321 |
|
|
Autore |
Holzer Dominik |
|
|
Titolo |
The BIM manager's handbook Change management . EPart 2 : guidance for professionals in architecture, engineering, and construction / / Dominik Holzer |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
West Sussex, England : , : Wiley, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (39 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Architects and builders |
Architectural practice |
Building - Computer simulation |
Building information modeling |
Building management - Data processing |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di contenuto |
|
The BIM Manager's Handbook: Guidance for Professionals in Architecture, Engineering, and Construction: Change Management: ePart 2; Change Management; Technology as a Driver for Innovation and Change; The Cultural Dimension of Change . . . and Its Management; The Social and Organizational Context to Change; BIM Managers: Facilitators of Change; Interfacing with Your Organization's Leadership and Management; BIM's Push and Pull; Decision Makers Who Do Not Understand BIM; Lacking Support from the Top; Becoming a Manager; Learning to Lobby; The Inside Man; Selling Value Back to the Business |
Overcoming Change Resistance and Managing ExpectationsThat BIM Thing Looks Amazing, Just Not on My Project!; Bridging the "Us vs. Them" Schism; Developing a Network; Tips and Tricks; The Design Technology and BIM Audit; Set Up and Run a Design Technology/BIM Audit:; What Should Be Asked During the Audit?; Change Management Workshops and Seminars; Endnotes; EULA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910557286503321 |
|
|
Autore |
MuÌller RuÌdiger |
|
|
Titolo |
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (260 p.) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
Rheumatoid Arthritis (RA) is a chronic inflammatory disease leading to joint inflammation and destruction. Treatment of RA includes the use of conventional (cs), biologic (b) disease-modifying anti-rheumatic drugs (DMARDs), and oral or intraarticular (IA) glucocorticoids (GCs). All different classes of drugs have shown to halt disease progression in clinical studies. In real life, a physician has more options than just adding or switching to a new ts/bDMARD if any kind of DMARDs has failed. They can modify or optimize the therapy with concomitant csDMARDs, and oral or IA-GC can be added to the treatment regimen. The EULAR states that therapeutic adjustment including the "optimization of csDMARDs dose or route of administration or intra-articular injections of GCs" is recommended. Thus, a new therapeutic agent can be embedded in a whole strategy with parallel optimization of the csDMARD and GC treatment. The idea of treating to target (T2T) for the treatment of RA patients has been around since the late 1990s. Many clinical studies (Ticora, BsSt, Camera) have demonstrated the superiority of a T2T approach. When I talk to physicians, I understand that most of them only rarely inject joints with GC. Therefore, I would like to create an issue on the T2T approach in reality including primary data, reviews, and real-life data demonstrating the general opinion and execution of T2T in treating RA. |
|
|
|
|
|
|
|
| |